Bonus BioGroup Ltd.
Tel Aviv Stock Exchange BONS.TA
Bonus BioGroup Ltd. Market Capitalization on January 14, 2025: USD 52.40 M
-
Bonus BioGroup Ltd. 52-week high Market Capitalization is USD 89.43 M on February 26, 2024, which is 70.65% above the current Market Capitalization.
-
Bonus BioGroup Ltd. 52-week low Market Capitalization is USD 29.07 M on December 18, 2024, which is -44.53% below the current Market Capitalization.
-
Bonus BioGroup Ltd. average Market Capitalization for the last 52 weeks is USD 48.02 M.
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
| CEO | Dr. Shai Meretzki Ph.D. |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | Matam Advanced Technology Park |
| Employees | 58 |
| Sector | Health Care |
| Industries | |
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases. Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email